Genetics of Parkinson's disease.

Fifteen years of genetic research in Parkinson's disease (PD) have led to the identification of several monogenic forms of the disorder and of numerous genetic risk factors increasing the risk to develop PD. Monogenic forms, caused by a single mutation in a dominantly or recessively inherited gene, are well-established, albeit relatively rare types of PD. They collectively account for about 30% of the familial and 3%-5% of the sporadic cases. In this article, we will summarize the current knowledge and understanding of the molecular genetics of PD. In brief, we will review familial forms of PD, basic genetic principles of inheritance (and their exceptions in PD), followed by current methods for the identification of PD genes and risk factors, and implications for genetic testing.

[1]  Chuong B. Do,et al.  Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database , 2012, PLoS genetics.

[2]  David W. Miller,et al.  α-Synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication , 2004, Neurology.

[3]  N. Pedersen,et al.  Heritability of Parkinson disease in Swedish twins: a longitudinal study , 2011, Neurobiology of Aging.

[4]  S. Pappatà,et al.  Mutation in the SYNJ1 Gene Associated with Autosomal Recessive, Early‐Onset Parkinsonism , 2013, Human mutation.

[5]  Z. Wszolek,et al.  Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes. , 2009, Parkinsonism & related disorders.

[6]  P. Pramstaller,et al.  Heterozygous PINK1 mutations: A susceptibility factor for Parkinson disease? , 2006, Movement disorders : official journal of the Movement Disorder Society.

[7]  A. Kakita,et al.  Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia. , 2008, Archives of neurology.

[8]  S. Minoshima,et al.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.

[9]  M. Farrer,et al.  Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries , 2006, Movement disorders : official journal of the Movement Disorder Society.

[10]  A. Varrone,et al.  PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism , 2006, Movement disorders : official journal of the Movement Disorder Society.

[11]  M. Farrer,et al.  Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication , 2007, Neurology.

[12]  J Q Trojanowski,et al.  A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of α-Synuclein Is Essential for Filament Assembly* , 2001, The Journal of Biological Chemistry.

[13]  Changan Jiang,et al.  Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin , 2006, Nature.

[14]  Marc N. Offman,et al.  A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. , 2011, American journal of human genetics.

[15]  J. Schulz,et al.  Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. , 2005, Human molecular genetics.

[16]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[17]  K. Lohmann,et al.  Clinical and demographic characteristics of PINK1 mutation carriers—A meta‐analysis , 2010, Movement disorders : official journal of the Movement Disorder Society.

[18]  Houeto Jean-Luc [Parkinson's disease]. , 2022, La Revue du praticien.

[19]  Hong Jiang,et al.  Mutations in NR4A2 associated with familial Parkinson disease , 2003, Nature Genetics.

[20]  A. Bonnet,et al.  EIF4G1 in familial Parkinson's disease: pathogenic mutations or rare benign variants? , 2012, Neurobiology of Aging.

[21]  R. Lipton,et al.  Olfactory dysfunction in LRRK2 G2019S mutation carriers , 2011, Neurology.

[22]  J. Trojanowski,et al.  Mechanisms of Parkinson's Disease Linked to Pathological α-Synuclein: New Targets for Drug Discovery , 2006, Neuron.

[23]  Christine Klein,et al.  Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes , 2005 .

[24]  P. Pollak,et al.  Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers , 2012, Neurology.

[25]  R. Barker,et al.  A case of late onset sporadic Parkinson’s disease with an A53T mutation in α-synuclein , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[26]  P. Bauer,et al.  PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism , 2005, European Journal of Human Genetics.

[27]  D. Elstein,et al.  The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. , 2005, The New England journal of medicine.

[28]  A. Lang,et al.  Deciphering the role of heterozygous mutations in genes associated with parkinsonism , 2007, The Lancet Neurology.

[29]  Michel Goedert,et al.  Alpha-synuclein and neurodegenerative diseases , 2001, Nature Reviews Neuroscience.

[30]  F. Brancati,et al.  Whole gene deletion and splicing mutations expand the PINK1 genotypic spectrum , 2007, Human mutation.

[31]  Timothy Lynch,et al.  Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. , 2005, American journal of human genetics.

[32]  D. Krainc,et al.  Zn²⁺ dyshomeostasis caused by loss of ATP13A2/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation. , 2014, Human molecular genetics.

[33]  N. Brüggemann,et al.  Mortalin mutations are not a frequent cause of early-onset Parkinson disease , 2013, Neurobiology of Aging.

[34]  C. Klein,et al.  Impact of recent genetic findings in Parkinson's disease , 2007, Current opinion in neurology.

[35]  Georg Auburger,et al.  The ubiquitin pathway in Parkinson's disease , 1998, Nature.

[36]  M. Farrer,et al.  Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism. , 2009, Parkinsonism & related disorders.

[37]  P. Pástor,et al.  PINK1-linked parkinsonism is associated with Lewy body pathology. , 2010, Brain : a journal of neurology.

[38]  N. Brüggemann,et al.  Mutations in PINK1 and Parkin Impair Ubiquitination of Mitofusins in Human Fibroblasts , 2011, PloS one.

[39]  M. Farrer,et al.  A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. , 1999, Human molecular genetics.

[40]  Alexandra Durr,et al.  How much phenotypic variation can be attributed to parkin genotype? , 2003, Annals of neurology.

[41]  H. Ischiropoulos,et al.  Molecular Neurodegeneration BioMed Central Review , 2009 .

[42]  V. Lee,et al.  Modeling Lewy pathology propagation in Parkinson's disease. , 2014, Parkinsonism & related disorders.

[43]  L. Racacho,et al.  Translated mutation in the Nurr1 gene as a cause for Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[44]  Matthew J. Farrer,et al.  LRRK2 in Parkinson's disease: protein domains and functional insights , 2006, Trends in Neurosciences.

[45]  W. Oyen,et al.  FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome , 2009, Neurology.

[46]  N. Quinn,et al.  “Atypical” atypical parkinsonism: New genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy—A diagnostic guide , 2013, Movement disorders : official journal of the Movement Disorder Society.

[47]  Yih-Ru Wu,et al.  LRRK2 G2385R modulates age at onset in Parkinson's disease: A multi‐center pooled analysis , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[48]  M. Ronaghi,et al.  Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays. , 2008, American journal of human genetics.

[49]  Christos Proukakis,et al.  A novel α-synuclein missense mutation in Parkinson disease , 2013, Neurology.

[50]  M. Farrer,et al.  VPS35 mutations in Parkinson disease. , 2011, American journal of human genetics.

[51]  Janel O. Johnson,et al.  Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease. , 2004, Archives of neurology.

[52]  M. Polymeropoulos,et al.  Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein. , 1999, American journal of human genetics.

[53]  M. Farrer,et al.  Low frequency of α‐synuclein mutations in familial Parkinson's disease , 1998, Annals of neurology.

[54]  D. Dickson,et al.  Leucine-Rich Repeat Kinase 2 Gene-Associated Disease: Redefining Genotype-Phenotype Correlation , 2010, Neurodegenerative Diseases.

[55]  C. Klein,et al.  The many faces of alpha‐synuclein mutations , 2013, Movement disorders : official journal of the Movement Disorder Society.

[56]  V. Álvarez,et al.  Mutational screening of the mortalin gene (HSPA9) in Parkinson’s disease , 2009, Journal of Neural Transmission.

[57]  T. Foroud,et al.  Mutations in DJ-1 are rare in familial Parkinson disease , 2006, Neuroscience Letters.

[58]  D. Eliezer,et al.  Structural effects of Parkinson's disease linked DJ‐1 mutations , 2008, Protein science : a publication of the Protein Society.

[59]  E. Tolosa,et al.  Identification of Spanish familial Parkinson's disease and screening for the Ala53Thr mutation of the α-synuclein gene in early onset patients , 1997, Neuroscience Letters.

[60]  A. Abeliovich,et al.  The Familial Parkinsonism Gene LRRK2 Regulates Neurite Process Morphology , 2006, Neuron.

[61]  A. Albanese,et al.  The PINK1 phenotype can be indistinguishable from idiopathic Parkinson disease , 2005, Neurology.

[62]  P. Stanzione,et al.  Late onset sporadic Parkinson's disease caused by PINK1 mutations: Clinical and functional study , 2008, Movement disorders : official journal of the Movement Disorder Society.

[63]  A. Destée,et al.  Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms. , 2009, Archives of neurology.

[64]  A. Lang,et al.  Motor and non-motor fluctuations. , 2007, Handbook of clinical neurology.

[65]  D. Perl The neuropathology of parkinsonism. , 2007, Handbook of clinical neurology.

[66]  Mark A. Wilson,et al.  The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Y. Sohn,et al.  Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease , 2008, Neurogenetics.

[68]  K. Lohmann,et al.  Genetics of Parkinson disease and other movement disorders. , 2012, Current opinion in neurology.

[69]  W. Dauer,et al.  Leucine-rich repeat kinase 2 for beginners: six key questions. , 2012, Cold Spring Harbor perspectives in medicine.

[70]  A Dürr,et al.  Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[71]  C. Ki,et al.  The Ala53Thr mutation in the α‐synuclein gene in a Korean family with Parkinson disease , 2007 .

[72]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[73]  J. Haines,et al.  The α-synuclein gene is not a major risk factor in familial Parkinson disease , 1999, Neurogenetics.

[74]  L. Honig,et al.  Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and Aβ accumulation , 2008, Proceedings of the National Academy of Sciences.

[75]  Apolipoprotein E genotype in familial Parkinson's disease. The French Parkinson's Disease Genetics Study Group. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[76]  M. Farrer,et al.  LRRK2: a common pathway for parkinsonism, pathogenesis and prevention? , 2006, Trends in molecular medicine.

[77]  Thomas Meitinger,et al.  Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.

[78]  Marc Cruts,et al.  Genetic Etiology of Parkinson Disease Associated with Mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 Genes: A Mutation Update , 2010, Human mutation.

[79]  P. Heutink,et al.  The DJ-1L166P mutant protein associated with early onset Parkinson's disease is unstable and forms higher-order protein complexes. , 2003, Human molecular genetics.

[80]  M. Farrer,et al.  Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson diseaseSYMBOL , 2008, Neurology.

[81]  M. Feany,et al.  α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease , 2005, Nature Neuroscience.

[82]  M. Pericak-Vance,et al.  Genetic complexity and Parkinson's disease. Deane Laboratory Parkinson Disease Research Group. , 1997, Science.

[83]  Philippe Amouyel,et al.  α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[84]  K. Marder,et al.  Frequency of LRRK2 mutations in early- and late-onset Parkinson disease , 2006, Neurology.

[85]  A. Brice,et al.  α-Synuclein gene duplication is present in sporadic Parkinson disease , 2008, Neurology.

[86]  E. Tolosa,et al.  Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study , 2008, The Lancet Neurology.

[87]  A. Brice Genetics of Parkinson's disease: LRRK2 on the rise. , 2005, Brain : a journal of neurology.

[88]  J. Trojanowski,et al.  Biochemical and pathological characterization of Lrrk2 , 2006, Annals of neurology.

[89]  F. Binkofski,et al.  Progression of subtle motor signs in PINK1 mutation carriers with mild dopaminergic deficit , 2010, Neurology.

[90]  Y. Agid,et al.  Genetic complexity and Parkinson's disease. , 1997, Science.

[91]  J. Langston,et al.  Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism. , 2009, Neurotoxicology.

[92]  E. Sidransky,et al.  Heterozygosity for a Mendelian disorder as a risk factor for complex disease , 2006, Clinical genetics.

[93]  Kazuko Hasegawa,et al.  An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family , 2005, Annals of neurology.

[94]  Janna H. Neltner,et al.  GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology , 2012, Neurology.

[95]  E. Sidransky,et al.  Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA) , 2008, Human mutation.

[96]  R. Youle,et al.  Mechanisms of mitophagy , 2010, Nature Reviews Molecular Cell Biology.

[97]  C. Klein,et al.  The genetics of Parkinson disease: implications for neurological care , 2006, Nature Clinical Practice Neurology.

[98]  A. Lang,et al.  Fixing the broken system of genetic locus symbols , 2012, Neurology.

[99]  D. Hernandez,et al.  Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease. , 2003, Human molecular genetics.

[100]  G. Dorn,et al.  PINK1-Phosphorylated Mitofusin 2 Is a Parkin Receptor for Culling Damaged Mitochondria , 2013, Science.

[101]  A. Tolun,et al.  DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability. , 2013, Parkinsonism & related disorders.

[102]  M. Farrer,et al.  Genomic investigation of α‐synuclein multiplication and parkinsonism , 2008, Annals of neurology.

[103]  C. Klein,et al.  Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes , 2005, Neurology.

[104]  Xin Zhao,et al.  Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[105]  Patrizia Rizzu,et al.  Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.

[106]  A. Ziegler,et al.  Next-generation phenotyping using the parkin example: time to catch up with genetics. , 2013, JAMA neurology.

[107]  C. Goetz,et al.  History of Parkinson's disease. , 2007, Handbook of clinical neurology.

[108]  D. Elstein,et al.  Increased incidence of Parkinson disease among relatives of patients with Gaucher disease. , 2006, Blood cells, molecules & diseases.

[109]  A. López de Munain,et al.  LRRK2 G2019S and R1441G mutations associated with Parkinson’s disease are common in the Basque Country, but relative prevalence is determined by ethnicity , 2009, neurogenetics.

[110]  J. Ioannidis,et al.  Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study , 2011, The Lancet Neurology.

[111]  E. Eisenberg,et al.  Multiple Roles of Auxilin and Hsc70 in Clathrin‐Mediated Endocytosis , 2007, Traffic.

[112]  G. Schellenberg,et al.  Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders. , 2008, Archives of neurology.

[113]  Nadezhda T. Doncheva,et al.  Profiling of Parkin-Binding Partners Using Tandem Affinity Purification , 2013, PloS one.

[114]  F. Binkofski,et al.  Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: role of a single hit? , 2006, Archives of neurology.

[115]  J. Burgunder,et al.  EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington’s disease, Parkinson’s disease and dystonias , 2009, European journal of neurology.

[116]  E. Sidransky,et al.  Glucocerebrosidase mutations in subjects with parkinsonism. , 2004, Molecular genetics and metabolism.

[117]  P. Vieregge,et al.  Attitudes of young patients with Parkinson's disease towards possible presymptomatic and prenatal genetic testing. , 2001, Genetic counseling.

[118]  Ramsay J. Hunt A SYSTEM DISEASE OF THE PARALYSIS AGITANS TYPE, CHARACTERIZED BY ATROPHY OF THE MOTOR CELLS OF THE CORPUS STRIATUMA CONTRIBUTION TO THE FUNCTIONS OF THE CORPUS STRIATUM , 1917 .

[119]  T. Ikeuchi,et al.  PROMINENT PSYCHIATRIC SYMPTOMS AND GLUCOSE HYPOMETABOLISM IN A FAMILY WITH A SNCA DUPLICATION , 2008, Neurology.

[120]  Jan Gründemann,et al.  Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase , 2006, Nature Genetics.

[121]  J. Stockman Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease , 2011 .

[122]  Bonifati,et al.  Association between early-onset Parkinson's disease and mutations in the parkin gene. , 2000, The New England journal of medicine.

[123]  Matthew J. Farrer,et al.  Comparison of kindreds with parkinsonism and α‐synuclein genomic multiplications , 2004 .

[124]  N. Hattori,et al.  Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism , 2005, Neurology.

[125]  M. Polymeropoulos,et al.  Mapping of a Gene for Parkinson's Disease to Chromosome 4q21-q23 , 1996, Science.

[126]  R. Hilker,et al.  Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers , 2005, Annals of neurology.

[127]  J W Langston,et al.  Parkinson disease in twins: an etiologic study. , 1999, JAMA.

[128]  I. Alafuzoff,et al.  α‐Synuclein pathology does not predict extrapyramidal symptoms or dementia , 2005, Annals of neurology.

[129]  K. Marder,et al.  Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. , 2010, Archives of neurology.

[130]  J. Hoenicka,et al.  The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.

[131]  C. Klein,et al.  Parkinson disease, 10 years after its genetic revolution: Multiple clues to a complex disorder , 2007, Neurology.

[132]  M. Farrer,et al.  The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients , 2005, Neuroscience Letters.

[133]  Andrew Lees,et al.  Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.

[134]  J. Hardy,et al.  Parkin disease: a clinicopathologic entity? , 2013, JAMA neurology.

[135]  M. Memo,et al.  Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease , 2012, EMBO molecular medicine.

[136]  A. Singleton,et al.  Clinical heterogeneity of α‐synuclein gene duplication in Parkinson's disease , 2006 .

[137]  R. Nussbaum,et al.  Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.

[138]  A. Reichert,et al.  Loss-of-Function of Human PINK1 Results in Mitochondrial Pathology and Can Be Rescued by Parkin , 2007, The Journal of Neuroscience.

[139]  K. Lohmann,et al.  Mutant Parkin Impairs Mitochondrial Function and Morphology in Human Fibroblasts , 2010, PloS one.

[140]  R. Krüger,et al.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. , 1998, Nature genetics.

[141]  T. Niki,et al.  Reduced anti-oxidative stress activities of DJ-1 mutants found in Parkinson's disease patients. , 2004, Biochemical and biophysical research communications.

[142]  V. Daggett,et al.  Molecular basis for the structural instability of human DJ-1 induced by the L166P mutation associated with Parkinson's disease. , 2008, Biochemistry.

[143]  A. Singleton,et al.  Parkinson's disease due to the R1441G mutation in Dardarin: A founder effect in the basques , 2006, Movement disorders : official journal of the Movement Disorder Society.

[144]  C. Lautier,et al.  Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease. , 2008, American journal of human genetics.

[145]  Janel O. Johnson,et al.  Parkin disease in a Brazilian kindred: Manifesting heterozygotes and clinical follow‐up over 10 years , 2005, Movement disorders : official journal of the Movement Disorder Society.

[146]  J. Ioannidis,et al.  A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease , 2011, Neurobiology of Aging.

[147]  Michael K. Hutchinson,et al.  Translation initiator EIF4G1 mutations in familial Parkinson disease. , 2011, American journal of human genetics.

[148]  C. Griesinger,et al.  Familial Mutants of α-Synuclein with Increased Neurotoxicity Have a Destabilized Conformation* , 2005, Journal of Biological Chemistry.

[149]  K. Reetz,et al.  Phenotypic spectrum of PINK1‐associated parkinsonism in 15 mutation carriers from 1 family , 2007, Movement disorders : official journal of the Movement Disorder Society.

[150]  Peter T. Lansbury,et al.  Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy , 2004, Science.

[151]  M. Vidailhet,et al.  Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease. , 2011, Human molecular genetics.

[152]  M. Farrer,et al.  α-Synuclein and Parkinson disease susceptibility , 2007, Neurology.

[153]  K. Kaestner,et al.  A Deleterious Mutation in DNAJC6 Encoding the Neuronal-Specific Clathrin-Uncoating Co-Chaperone Auxilin, Is Associated with Juvenile Parkinsonism , 2012, PloS one.

[154]  J. Nutt,et al.  LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago. , 2006, American journal of human genetics.

[155]  N. Wood,et al.  PINK1 (PARK6) associated Parkinson disease in Ireland , 2004, Neurology.

[156]  N. Brüggemann,et al.  Dopa-responsive dystonia revisited: diagnostic delay, residual signs, and nonmotor signs. , 2012, Archives of neurology.

[157]  P. Pollak,et al.  LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. , 2006, The New England journal of medicine.

[158]  A. Björklund,et al.  NURR1 in Parkinson disease—from pathogenesis to therapeutic potential , 2013, Nature Reviews Neurology.

[159]  M. Farrer,et al.  A Swedish family with de novo alpha-synuclein A53T mutation: evidence for early cortical dysfunction. , 2009, Parkinsonism & related disorders.

[160]  Irene Litvan,et al.  Lrrk2 and Lewy body disease , 2006, Annals of neurology.

[161]  Wyeth W Wasserman,et al.  DNAJC13 mutations in Parkinson disease. , 2014, Human molecular genetics.

[162]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[163]  Vladimir Makarov,et al.  The Sac1 Domain of SYNJ1 Identified Mutated in a Family with Early‐Onset Progressive Parkinsonism with Generalized Seizures , 2013, Human mutation.

[164]  Patrick A. Lewis,et al.  Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus , 2011, Nature communications.

[165]  J. Ioannidis,et al.  A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants , 2012, Journal of Medical Genetics.

[166]  Aldo Quattrone,et al.  Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. , 2006, JAMA.

[167]  M. Farrer,et al.  Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.

[168]  J. Hardy,et al.  Study of the genetic variability in a Parkinson's Disease gene: EIF4G1 , 2012, Neuroscience Letters.

[169]  J. Nutt,et al.  Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[170]  M. Farrer,et al.  A Swedish family with de novo α -synuclein A53T mutation: Evidence for early cortical dysfunction , 2009 .

[171]  O. Levy,et al.  The neuropathology of genetic Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[172]  Ying Sun,et al.  Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies , 2011, Cell.

[173]  A. Ziegler,et al.  From GWAS to clinical utility in Parkinson's disease , 2011, The Lancet.

[174]  N. Hattori,et al.  Leucine-Rich Repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population , 2007, Neuroreport.

[175]  R. Nussbaum,et al.  Parkinsonism among Gaucher disease carriers , 2004, Journal of Medical Genetics.

[176]  U Inserm,et al.  Causal relation between α synuclein gene duplication and familial Parkinson’s disease , 2005 .

[177]  Beate Ritz,et al.  α-Synuclein Genetic Variants Predict Faster Motor Symptom Progression in Idiopathic Parkinson Disease , 2012, PloS one.

[178]  V. Lee,et al.  Alpha-synuclein: normal function and role in neurodegenerative diseases. , 2004, Current topics in developmental biology.

[179]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[180]  Heidi Phillips,et al.  Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System , 2000, Neuron.

[181]  Daniel Offen,et al.  DJ-1 protects against dopamine toxicity , 2009, Journal of Neural Transmission.

[182]  A. Singleton,et al.  Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: Phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations , 2009, Movement disorders : official journal of the Movement Disorder Society.

[183]  Christine Klein,et al.  LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. , 2006, The New England journal of medicine.

[184]  M. Farrer,et al.  Expanding the clinical phenotype of SNCA duplication carriers , 2009, Movement disorders : official journal of the Movement Disorder Society.

[185]  M. Cookson,et al.  Genetic neuropathology of Parkinson's disease. , 2008, International journal of clinical and experimental pathology.

[186]  A. Brice,et al.  A new complex homozygous large rearrangement of the PINK1 gene in a Sudanese family with early onset Parkinson’s disease , 2009, neurogenetics.

[187]  B. Jeon,et al.  α-Synuclein gene duplication is present in sporadic Parkinson disease , 2008, Neurology.

[188]  Olaf Riess,et al.  AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.

[189]  A. Bentivoglio,et al.  PINK1 mutations are associated with sporadic early‐onset parkinsonism , 2004, Annals of neurology.

[190]  J. Jankovic,et al.  Motor symptoms in Parkinson's disease. , 2007, Handbook of clinical neurology.

[191]  Glenda M. Halliday,et al.  Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr α‐synuclein mutation , 2001 .

[192]  A. Lang,et al.  The curious case of phenocopies in families with genetic Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.